No Evidence of Plasmodium falciparum k13 Artemisinin Resistance-Conferring Mutations over a 24-Year Analysis in Coastal Kenya but a Near Complete Reversion to Chloroquine-Sensitive Parasites

Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis

(2019) Anna Maria van Eijk et al.   LANCET INFECTIOUS DISEASES

Prevalence of Plasmodium falciparum delayed clearance associated polymorphisms in adaptor protein complex 2 mu subunit (pfap2mu) and ubiquitin specific protease 1 (pfubp1) genes in Ghanaian isolates

(2018) Tryphena Adams et al.   Parasites & Vectors

Consistent signatures of selection from genomic analysis of pairs of temporal and spatial Plasmodium falciparum populations from The Gambia

(2018) Alfred Amambua-Ngwa et al.   Scientific Reports

The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study

(2017) Mallika Imwong et al.   LANCET INFECTIOUS DISEASES

Emergence of Plasmodium falciparum triple mutant in Cambodia

(2017) Gabriele Rossi et al.   LANCET INFECTIOUS DISEASES

The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016

(2017) Anne Musuva et al.   MALARIA JOURNAL

Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa

(2017) Feng Lu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa

(2017) Lucy C. Okell et al.   Scientific Reports

West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether–Lumefantrine in Senegal, Mali, and The Gambia

(2016) Baba Dieye et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Natural selection of K13 mutants of Plasmodium falciparum in response to artemisinin combination therapies in Thailand

(2016) C. Putaporntip et al.   CLINICAL MICROBIOLOGY AND INFECTION

Comparative genome-wide analysis and evolutionary history of haemoglobin-processing and haem detoxification enzymes in malarial parasites

(2016) Patrath Ponsuwanna et al.   MALARIA JOURNAL

A Worldwide Map ofPlasmodium falciparumK13-Propeller Polymorphisms

(2016) Didier Ménard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genomic epidemiology of artemisinin resistant malaria

(2016)   eLife

Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V

(2016) Mary C. Oguike et al.   International Journal for Parasitology-Drugs and Drug Resistance

How genomics is contributing to the fight against artemisinin-resistant malaria parasites

(2015) Pedro Cravo et al.   ACTA TROPICA

Emergence of Mutations in the K13 Propeller Gene of Plasmodium falciparum Isolates from Dakar, Senegal, in 2013-2014

(2015) Agathe Boussaroque et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Artemisinin Resistance at the China-Myanmar Border and Association with Mutations in the K13 Propeller Gene

(2015) Zenglei Wang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight

(2015) Meghna Desai et al.   CLINICAL INFECTIOUS DISEASES

Prevalence ofPlasmodium falciparumparasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistantpfdhfr/pfdhpsalleles

(2015) Pamela Chauvin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Genetic architecture of artemisinin-resistant Plasmodium falciparum

(2015) Olivo Miotto et al.   NATURE GENETICS

Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether–lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya

(2015) Angela O. Achieng et al.   International Journal for Parasitology-Drugs and Drug Resistance

AliView: a fast and lightweight alignment viewer and editor for large datasets

(2014) Anders Larsson   BIOINFORMATICS

Directional Selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu Loci of Plasmodium falciparum in Kenyan Children Treated With ACT

(2014) Gisela Henriques et al.   JOURNAL OF INFECTIOUS DISEASES

K13-Propeller Polymorphisms in Plasmodium falciparum Parasites From Sub-Saharan Africa

(2014) E. Kamau et al.   JOURNAL OF INFECTIOUS DISEASES

Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012–2013

(2014) Marylin Torrentino-Madamet et al.   MALARIA JOURNAL

Spread of Artemisinin Resistance in Plasmodium falciparum Malaria

(2014) Elizabeth A. Ashley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya

(2014) John Okombo et al.   International Journal for Parasitology-Drugs and Drug Resistance

The Polymorphic Linker Domain ofpfmdr1Is Associated with Resistance-Conferring Mutations in Plasmodium falciparum Populations from East and West Africa

(2013) John Okombo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania

(2013) Maja Malmberg et al.   MALARIA JOURNAL

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria

(2013) Frédéric Ariey et al.   NATURE

The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008–2011

(2013) Fredrick L. Eyase et al.   PLoS One

Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya

(2012) Clarence M. Mang’era et al.   ACTA TROPICA

Increasedpfmdr1Copy Number and Sequence Polymorphisms in Plasmodium falciparum Isolates from Sudanese Malaria Patients Treated with Artemether-Lumefantrine

(2011) Nahla B. Gadalla et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Limited Geographical Origin and Global Spread of Sulfadoxine-Resistant dhps Alleles in Plasmodium falciparum Populations

(2011) Toshihiro Mita et al.   JOURNAL OF INFECTIOUS DISEASES

Selective Sweeps and Genetic Lineages of Plasmodium falciparum Drug -Resistant Alleles in Ghana

(2010) Md Tauqeer Alam et al.   JOURNAL OF INFECTIOUS DISEASES

In Vivo and In Vitro Efficacy of Amodiaquine againstPlasmodium falciparumin an Area of Continued Use of 4‐Aminoquinolines in East Africa

(2009) Philip Sasi et al.   JOURNAL OF INFECTIOUS DISEASES

In Vivo Selection ofPlasmodium falciparumParasites Carrying the Chloroquine-SusceptiblepfcrtK76 Allele after Treatment with Artemether-Lumefantrine in Africa

(2009) Christin Sisowath et al.   JOURNAL OF INFECTIOUS DISEASES

Chloroquine resistance before and after its withdrawal in Kenya

(2009) Leah Mwai et al.   MALARIA JOURNAL

Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia

(2009) Pharath Lim et al.   MALARIA JOURNAL

Artemisinin Resistance inPlasmodium falciparumMalaria

(2009) Arjen M. Dondorp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evidence of Artemisinin-Resistant Malaria in Western Cambodia

(2008) Harald Noedl et al.   NEW ENGLAND JOURNAL OF MEDICINE